Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: IEEE EMBS Int Conf Biomed Health Inform. 2018 Apr 9;2018:17–20. doi: 10.1109/BHI.2018.8333359

Table III.

Distribution of statistical features extracted for activity data for all groups.

Variable Control-ICU, N=3 CCI, N=5 RR, N=6 Control-healthy, N=10 pa
Min 0.55 (0.39, 1.02) 0.99 (0.67, 1.06) 1.94 (0.84, 2.61) 0.79 (0.49, 1.13) 0.475
Amplitude 0.72 (0.44, 1.07)b 0.77 (0.60, 1.08)b 0.81 (0.61, 2.43)b 5.64 (4.97, 6.04)c,d,e <0.001
Phase 6.21 (4.71, 10.66) 13.09 (12.81, 15.71) 15.41 (13.67, 16.14) 14.75 (13.78, 15.23) 0.281
Alpha −0.13 (−0.15, 0.43)b 0.20 (−0.65, 0.27) −0.50 (−0.74, −0.04) −0.44 (−0.47, −0.35)e 0.249
Beta 27.34 (16.02, 291.46) 51.77 (40.81, 56.69) 48.13 (18.91, 78.86) 14.47 (8.16, 33.93) 0.398

Control-ICU: non-sepsis ICU patients, CCI: chronic critical illness, RR: rapid recovery, control-healthy: healthy subjects. Data are median and interquartile range (25%, 75%) values.

a

Kruskal-Wallis analysis of variance by ranks

b

significantly different from control-healthy patients (p<0.01)

c

significantly different from CCI patients (p<0.05)

d

significantly different from RR patients (p<0.05)

e

significantly different from control-ICU patients (p<0.05). N: number of patients.